CURCUMIN AS CHEMOSENSITIZER
- 1 January 2007
- book chapter
- Published by Springer Nature
- Vol. 595, 269-300
- https://doi.org/10.1007/978-0-387-46401-5_12
Abstract
This overview presents curcumin as a significant chemosensitizer in cancer chemotherapy. Although the review focuses on curcumin and its analogues on multidrug resistance (MDR) reversal, the relevance of curcumin as a nuclear factor (NF)-κB blocker and sensitizer of many chemoresistant cancer cell lines to chemotherapeutic agents will also be discussed. One of the major mechanisms of MDR is the enhanced ability of tumor cells to actively efflux drugs, leading to a decrease in cellular drug accumulation below toxic levels.This publication has 139 references indexed in Scilit:
- Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin PolymerizationJournal of Biological Chemistry, 2005
- Interplay between MRP Inhibition and Metabolism of MRP Inhibitors: The Case of CurcuminChemical Research in Toxicology, 2003
- Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer CellsBiochemical and Biophysical Research Communications, 2001
- The Hallmarks of CancerCell, 2000
- Experimental modulation of MRP (multidrug resistanceassociated protein)-mediated resistanceEuropean Journal Of Cancer, 1996
- MDR1 gene expression in solid tumoursEuropean Journal Of Cancer, 1996
- Clinical multidrug resistance in cancer: A multifactorial problemEuropean Journal Of Cancer, 1996
- Multidrug resistance in breast cancer: Mechanisms, strategiesEuropean Journal Of Cancer, 1995
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1)FEBS Letters, 1992